Company / Operating Income per Share
NeoGenomics Laboratories, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.90
FY2025
5-year range
-$1.27 / -$0.73
FY2021-FY2025
Trend
-24.4%
vs FY2024
Sector context
#121 of 154
Health Care
What the data says
NeoGenomics Laboratories, Inc.'s operating income per share of $-0.90 is lower than 79% of companies in the Health Care sector (FY2025). Operating Income per Share has fluctuated over the past 10 years, ranging from $-1.27 in FY2022 to $0.13 in FY2019.
Based on SEC 10-K filings.
-0.90 in FY2025.
Declined from $-0.86 to $-0.90 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 154This company -$0.90 Sector average $4.25
▼
-121.3% below sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 24.4% year-over-year.
- Ranks #121 out of 154 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2019.
- Lowest operating income per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.90 | -24.4% |
| FY2024 | -$0.73 | +15.3% |
| FY2023 | -$0.86 | +32.3% |
| FY2022 | -$1.27 | -28.2% |
| FY2021 | -$0.99 | -690.9% |
| FY2020 | -$0.13 | -199.7% |
| FY2019 | $0.13 | +14.5% |
| FY2018 | $0.11 | +196.9% |
| FY2017 | $0.04 | +29.9% |
| FY2016 | $0.03 | +130.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026